Eritrea vs South Africa: Population requiring preventive chemotherapy for schistosomiasis
Eritrea
813,233
in 2024
South Africa
506,732
in 2024
Eritrea rank
36th
South Africa rank
39th
Population requiring preventive chemotherapy for schistosomiasis over time
- Eritrea
- South Africa
How they compare
Eritrea currently reports 813,233 against 506,732 in South Africa, a difference of 306,501.
That makes Eritrea's figure about 1.6 times South Africa's.
The two have swapped places 1 time across 15 shared years of data; in 2010 it was South Africa ahead.
Eritrea ranks 36th and South Africa ranks 39th of 52 countries.
South Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eritrea | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 396,063 | 5.28 million | 4.89 million | South Africa |
| 2020s | 526,152 | 2.98 million | 2.45 million | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Eritrea or South Africa?
- Eritrea, at 813,233 against 506,732 in South Africa as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Eritrea and South Africa?
- 306,501, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and South Africa?
- 15 years are reported by both, from 2010 to 2024.
- How do Eritrea and South Africa rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Eritrea ranks 36th and South Africa ranks 39th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.